by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Nov 6, 2015 | Drug Importation, Drug Prices, Generic drugs, Government
Americans should know about the heat coming down against the pharmaceutical industry from certain members of Congress in an effort to combat the public health crisis of high drug prices. This week, nine lawmakers from the House of Representatives announced the formation of a new group called the Affordable Drug Pricing Task Force. Its goals are clear, to lower cost barriers to life saving medication and to demand greater transparency about drug cost decisions made by the pharmaceutical industry.
Two pertinent facts were continually raised. One, high drug prices are the No. 1 healthcare issue in America. Two, medication prices are much lower in other countries, about 50% lower in the UK.
To announce the task force, a press conference was led by Congressman Lloyd Doggett (D-TX) and included speeches by Rep. Sander Levin (D-MI), Rep. Jan Schakowsky (D-MI), Rep. Jim McDermott (D-WA), Rep. Rosa DeLauro (D-CT), Rep. Peter Welch (D-VT), Rep. Marcy Kaptur (D-OH), Rep. David Cicilline (D-RI), and Congressman Elijah Cummings (D-MD). We wrote about Rep. Cummings’ efforts a couple of weeks back as Congressman Cummings noted PharmacyChecker.com as a supporter of the Prescription Drug Affordability Act of 2015. I also want to note thank Congresswoman DeLauro for recently becoming a co-sponsor of the Personal Drug Importation Fairness Act of 2015.
The speakers have supported a variety of solutions to lowering drug prices, including allowing Medicare to negotiate drug prices with pharmaceutical companies; ending “pay-for-delay,” a practice sometimes described as payoffs by brand drug patent holders to generic drug companies to that the latter will postpone launching a lower cost generic; reforming prescription drug importation laws to make it easier to access lower cost medications from other countries; and greater oversight into pharmaceutical industry pricing practices.
Some highlighted quotes or phrases:
- “If the people are not able to afford their prescriptions that means they suffer and in some instances they die.” Rep. Cummings.
- McDermott’s take: “The pharmaceutical companies have got the Congress in the palm of their hand and they will not let us go.”
- The problem of high drug prices was referred to as an “emergency situation” by Rep. Sander Levin.
It’s no secret that I support much of this agenda. But what is needed is bipartisanship, and I’m waiting for these leaders, as part of their noble effort, to consider looking critically at the Obama administration’s record on personal drug importation and online pharmacies. Candidate Obama in 2007 supported reforming the law to make it easier for Americans to import lower cost medication. Unfortunately, in its efforts to pass the Affordable Care Act, which I supported, the Obama administration made a deal with big pharma to change course and dump drug importation legal reform in exchange for pharma’s support for Obamacare and agreement to new discounts on Medicare Part D medications through the coverage gap (the “Donut hole”).
On that final note, the Obama administration, though the Department of Health and Human Services (HHS), has announced a forum on drug prices to be held on November 20th. Maybe we’ll learn that the Obama administration’s position on prescription drug importation has returned to one more in line with most Americans. We’ll keep our fingers crossed.
(You can view the complete press conference below)
Members of the newly formed Affordable Drug Pricing Task Force will hold a press conference announcing meaningful action to combat the skyrocketing costs of pharmaceuticals. Who: Reps. Cummings, Doggett, McDermott, DeLauro, Schakowsky, and Welch.
Affordable Drug Pricing Task Force Press Conference – Nov 4, 2015
Tagged with: Affordable Drug Pricing Task Force, Congress, David Cicilline, Drug Importation, Elijah Cummings, generic drugs, Jan Schakowsky, Jim McDermott, Marcy Kaptur, Online Pharmacies, Personal Drug Importation Fairness Act, Peter Welch, Rosa DeLauro, Sander Levin, United States
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Oct 30, 2015 | Drug Prices, Medicare Drug Plans
We’re two weeks into the open enrollment period of Part D Medicare Drug Plans and it is my deepest hope that if you are a Medicare enrollee then you are taking time to find the best plan. It’s not easy. Finding the right plan, however, could mean getting the medications you need to stay healthy, saving money, and avoiding lots of headaches throughout the year. Our website, MedicareDrugPlans.com, gives you basic information, such as premiums, deductibles and coverage levels, but also ratings and reviews about Part D plans that can inform you about the experiences of your peers in using the different plans. Your final search should be with the government’s website – Medicare Plan Finder – where you can find the plans that cover the medications you are already taking now and specific costs related to those plans. Below are key points about costs and coverage.
Part D Plan Costs
Plan costs have gone up this year. The deductible cap increased by 12.5%, from $320 to $360. Fifty-three percent of the plans are charging the full deductible, while the other 47% charge less. Average premiums have increased from $36.68 in 2015 to $41.46 in 2016. The lowest monthly premium is $6.80, that’s if you live in Puerto Rico and choose the Humana Preferred Rx Plan. The highest premium is $174.70, that’s if you live in Florida and choose Blue MedicareRx Option 2.
Part D Plan Choices
The overall trend of having fewer Part D plans to choose from continues this enrollment season, down to 886 this year compared to 1001 last year. Looked at historically, the declines are even more striking, as there were 1,875 plans in 2007. These numbers are the totals available in all states and U.S. territories but options are really state-based. Alaskans had only 19 plans to choose from, compared to a high of 29 in West Virginia and Pennsylvania.
Part D Plan Coverages Phases
There are four coverage phases for Part D plans: deductible, initial coverage period, the coverage gap, often referred to as the “donut hole,” and catastrophic coverage. The deductible is pretty straightforward–you pay the full cost of your medications up until that dollar amount, which can be as high as $360. During the initial coverage period, you usually pay about 25% of drug costs and the plan picks up 75% until total costs have reached $3,310. At that point you’re in the coverage gap, but you’re paying discounted prices, 45% and 58% of brand and generic drug costs, respectively. Once total costs have exceeded $7,515, you are in catastrophic coverage territory, and only have to pay 5% of your total drug costs until the next year begins.
Understanding these generalities about Part D plans is important, but the devil is in the details, which can only be understood through research. It’s not enough to just stick with the plan you have. Nine out of 10 Medicare enrollees do not change plans, and many end up with higher drug costs because they don’t. The landscape of plans changes every year; so do your research, shop around, and get the best plan for your health and wallet!
For a thorough plan analysis see Kaiser Family Foundation.
For ratings and reviews, check out www.medicaredrugplans.com.
To finalize your decision go to Medicare Plan Finder.
Tagged with: donut hole, Kaiser Family Foundation, Medicare Drug Plans, Medicare Part D, medicare plan finder, Medicare.gov, medicaredruglans.com
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Oct 23, 2015 | Drug Importation, Government
In his article for AFRO – “A Growing National Outcry for Lower Prescription Drug Prices” – we were pleased to be noted by Congressman Elijah Cummings (D-MD) as a supporter of the Prescription Drug Affordability Act of 2015, and one of several organizations, including Public Citizen, Families USA, and Knowledge Ecology International that “speak of millions of Americans.” The bill was also introduced in the Senate by Senator Bernie Sanders (I-VT), who is a candidate for the Democratic Primary.
Rep. Cummings highlights the fact that American public opinion is overwhelmingly in favor of legal and regulatory reform to bring down drug prices. His legislation calls for Medicare to negotiate drug prices with drug companies, ending “pay-to-delay” deals, which are often characterized as payoffs from brand to generic drug companies to postpone introducing a lower cost generic, and reforming drug importation laws to expand our access to lower cost medications in other countries.
PharmacyChecker.com is not taking sides in a partisan fashion. Republicans, Democrats, and independents agree on the urgency of tackling drug prices in America. Sen. John McCain (R-AZ), Charles Grassley (R-IW), and David Vitter (R-LA) have all introduced and sponsored drug importation reform legislation over the past few years that we support. Another example is Republican presidential candidate Mike Huckabee, who wrote an op-ed strongly in favor of legal reform of drug importation to help Americans buy lower cost medications from Canada.
The most critical factor is that we move in the right direction towards expanding access to affordable medication, and we salute Congressman Cummings for doing so.
Tagged with: Bernie Sanders, Charles Grassley, Congress, David Vitter, drug importation reform legislation, drugs from canada, Elijah Cummings, John McCain, Mike Huckabee, personal drug importation, Prescription Drug Affordability Act of 2015
by PharmacyChecker.com | Oct 16, 2015 | Drug Prices
“Migraine” by Sasha Wolff from Grand Rapids – Can’t Concentrate: 14/365. Licensed under CC BY 2.0 via Wikimedia Commons.
Dr. David Belk, a practicing physician in California, healthcare cost research guru and Huffington Post blogger, recently wrote a story about the huge difference in price faced by one of his patients when trying to fill a prescription for the migraine medication called Maxalt (rizatriptan). Since my daughter suffers from migraines, I know how debilitating migraine headache can be and how important it is to have the medication when you need it.
Essentially, Dr. Belk discovered that Walgreens, a big chain pharmacy, was charging much more money than another pharmacy – in this case Costco. The price for the generic at Walgreens without insurance was $1,490 for 40 pills, or $37 a pill, and even with insurance the price was almost $17 dollars a pill. But Dr. Belk’s patient ended up getting the medication at Costco for $1.03 per pill!!
Now ordinarily here’s where we’d write about how you might consider PharmacyChecker- verified international online pharmacies to purchase Maxalt or rizatriptin if you don’t have insurance – but you would not need to. According to Dr. Belk’s post, Costco’s price was the cash price! None of the online pharmacies in our program sell it for just over a buck a pill. It’s the cheapest in the U.S.A.!
A few months back, Tod Cooperman, MD, founder of PharmacyChecker.com was on Fox and Friends talking about another big chain pharmacy, one accused of overcharging consumers for generic medications. It seems that the problem is not just Big Pharma but Big Pharmacy.
Drug prices these days seem to be all over the place. The moral of this story: shop around as much as possible and don’t trust your friendly neighborhood chain pharmacy or assume that international online pharmacies are cheapest. I know it’s enough to give you a headache, even a migraine, but finding the lowest drug prices will help lessen the pain.
Tagged with: Dr. David Belk, Drug Prices, Huffington Post, maxalt, migraine, rizatriptan, Tod Cooperman, walgreens
by PharmacyChecker.com | Oct 9, 2015 | Drug Importation, Drug Prices, FDA
“Abstract pills” by Robson – Flickr
We issued a press release yesterday about our new drug price savings analysis, which shows that consumers can save 84% on average among a basket of 10 popular branded maintenance medications if purchased from verified international online pharmacies instead of local U.S. pharmacies. Many of the savings are over 90%! The greatest savings is 94% for the acid-blocking drug Nexium ($946.50 in the U.S. vs. $53.09 online for a three month supply of 40 mg pills) and the cholesterol-lowering drug Crestor ($803.89 vs. $51.40 – 20 mg pills). The greatest dollar savings is for the antipsychotic drug Abilify ($3,178.99 vs. $237.05 – 10 mg pills). The average annual savings per drug is $3,479. Despite this, last month, the U.S. FDA announced a “new rule” regarding its expanded authority to destroy personally imported medicine under Section 708 of the Food and Drug Administration Safety Act of 2012. Several members of congress have raised concern that FDA’s rules may impede access to affordable medication. [1]
The FDA says that its new regulation is meant to protect patients from unsafe medications and counterfeit drugs but the agency doesn’t seem to say how they will distinguish safe from potentially unsafe personal drug imports.
For the full press release, click here.
Prices for a 3-month supply of top-selling brand name medications
| Drug |
Local U.S. Pharmacy Price |
International Online Pharmacy Price* |
International Online Savings |
Annual Savings |
| Nexium 40mg |
$946.50 |
$53.09 |
94% |
$3,573.64 |
| Crestor 20mg |
$803.89 |
$51.40 |
94% |
$3,009.96 |
| Abilify 10mg |
$3,178.99 |
$237.05 |
93% |
$11,767.75 |
| Advair Diskus 250/50mcg (180 doses) |
$1,203.00 |
$99.99 |
92% |
$4,412.04 |
| Spiriva Handihaler 18mcg |
$1,221.00 |
$113.99 |
91% |
$4,428.04 |
| Diovan 80mg |
$611.99 |
$57.85 |
91% |
$2,216.56 |
| Synthroid 100mcg |
$137.99 |
$26.99 |
80% |
$444.00 |
| Jardiance 10mg |
$1,150.00 |
$287.99 |
75% |
$3,448.04 |
| Ventolin HFA 100mcg |
$192.00 |
$68.82 |
64% |
$492.72 |
| Lantus Solostar 15ml |
$397.89 |
$148.94 |
63% |
$995.80 |
| Average |
$984.33 |
$114.62 |
84% |
$3,478.85 |
Sources: Local pharmacy prices based on prices at chain drugstores in New York City; International online pharmacy prices based on lowest prices listed on PharmacyChecker.com. All prices obtained on September 30, 2015.
*Medications dispensed by licensed pharmacies, verified by PharmacyChecker.com, in one of the following countries Australia, Barbados, Canada, India, Mauritius, New Zealand, Turkey, Singapore, or United Kingdom.
[1] U.S. Senator David Vitter, “Vitter Fights to Keep Prescription Drug Prices Affordable Through Reimportation,” July 9, 2014 [press release], see [www] vitter.senate.gov/newsroom/press/vitter-fights-to-keep-prescription-drug-prices-affordablethrough-reimportation [Last accessed 9/20/14]. 38 Representative JoAnn Emerson (MO), “Food and Drug Administration Reform Act.” May 30th 2012. See [www] votesmart.org/public-statement/702416/food-and-drug-administration-reform-act-of-2012#.UxVJN-co4s9 [Last accessed 9/22/14]. Letter to the U.S. Food and Drug Administration by Congressman Keith Ellison dated July 1st, 2014. See See [www] regulations.gov/#!documentDetail;D=FDA-2014-N-0504-0022.
Tagged with: brand name drugs, Drug Prices, FDA, Food and Drug Administration Safety Act, international pharmacies, Online Pharmacies, personal drug importation
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Oct 2, 2015 | Drug Prices
Contrary to the belief of the pharmaceutical industry and their minions, PharmacyChecker.com is not a champion of foreign online pharmacies, even the safest ones. They just charge a lot less for medication, which helps American consumers stay healthy and avoid bankruptcy. But they are, like their U.S. pharmacy counterparts, just businesses.
And that brings us back to our blog topic from last week, which was Daraprim, the parasite-fighting drug that, in the blink of an eye, went from $13.50/pill to $750/pill in the U.S. a few weeks back. We wrote what seemed impossible: a 99.8% international pharmacy savings on a medication. When we published that post, the price of Daraprim, manufactured and marketed by GlaxoSmithKline in Europe, was $1.53 a pill at the lowest cost international online pharmacy in the PharmacyChecker Verification Program. Well, those international online pharmacies jacked their prices, too…kind of.
As PharmacyChecker founder Tod Cooperman, MD, was writing an article for the Huffington Post about Daraprim, prescription drug importation and overall drug affordability problems, we discovered that the online price of Daraprim 25mg jumped from $1.53 a pill to $6 bucks! An increase of 292%.
It was reported that the villain of this whole story, the head of Turing Pharmaceuticals, the company that owns Daraprim in the U.S., was planning on lowering the price of Daraprim, which appeared to be an almost necessary public relations move. I called chain pharmacy giant Walgreens today expecting that the price would be less than $750 but found out that the price was actually $796/pill.
So the potential international drug price savings on Daraprim has plummeted from 99.8% to 99.25% A little Rx irony to end our week here at PharmacyChecker.com.
Tagged with: cooperman, deraprim, Huffington Post, turing, walgreens
